Sugi Predict

Sugi Predict / Compounds / SCHEMBL10026540

SCHEMBL10026540

SCHEMBL10026540

Cc1cc(-c2cc(C)c(N)c3ccccc23)c2ccccc2c1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 6/20 0.39
▸ TSHR P16473 2/20 0.39
▸ CYP2A6 P11509 2/20 0.39
▸ PKM P14618 1/20 0.38
▸ BACE1 P56817 1/20 0.37
▸ POLB P06746 2/20 0.37
▸ CYP1A1 P04798 1/20 0.36
▸ ALDH1A1 P00352 4/20 0.36
▸ CYP3A4 P08684 2/20 0.36
▸ TDP1 Q9NUW8 2/20 0.36
▸ TP53 P04637 1/20 0.36
▸ EP300 Q09472 1/20 0.35
▸ HPGD P15428 3/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ LMNA P02545 2/20 0.34
▸ GAA P10253 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL866443 0.91 CYP1A2 (0.43) CYP1A2TSHRCYP2A6PKMBACE1
SCHEMBL29462977 0.91 CYP1A2 (0.43) CYP1A2TSHRCYP2A6PKMBACE1
SCHEMBL19308940 0.87 CYP1A2 (0.48) CYP1A2TSHRCYP2A6PKMBACE1
SCHEMBL20202780 0.80 PKM (0.40) CYP1A2TSHRCYP2A6PKMBACE1
SCHEMBL29999289 0.78 CYP1A2 (0.50) CYP1A2TSHRCYP2A6PKMBACE1
SCHEMBL1562090 0.78 CYP1A2 (0.50) CYP1A2TSHRCYP2A6PKMBACE1
SCHEMBL29405295 0.76 PKM (0.63) CYP1A2TSHRPKMBACE1POLB
SCHEMBL352532 0.76 PKM (0.63) CYP1A2TSHRPKMBACE1POLB
SCHEMBL5749741 0.74 ACHE (0.48) CYP1A2TSHRCYP2A6PKMBACE1
Hydrochloric Acid SCHEMBL10719596 0.74 PKM (0.61) CYP1A2TSHRPKMBACE1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9840514-B2 Dianhydrides, polyimides, methods of making each, and methods of use KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) 2017-12-12 — — US disclosed
US-9751985-B2 Triptycene-based dianhydrides, polyimides, methods of making each, and methods of use KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) 2017-09-05 — — US disclosed
US-20160152630-A1 DIANHYDRIDES, POLYIMIDES, METHODS OF MAKING EACH, AND METHODS OF USE KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) 2016-06-02 — — US disclosed
US-8173842-B2 Multifunctional linker molecules for tuning electronic charge transport through organic-inorganic composite structures and uses thereof SONY DEUTSCHLAND GMBH (DE) 2012-05-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160152630-A1 DIANHYDRIDES, POLYIMIDES, METHODS OF MAKING EACH, AND METHODS OF USE ALKBH3, ALK, DDC CYP1A2 4003/4885TSHR 4669/4885CYP2A6 3095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.